1. Dual Mechanism of Action: The Esomeprazole component effectively reduces stomach acid secretion by blocking proton pumps in the gastric lining, providing relief from heartburn and acid regurgitation. Domperidone enhances gastrointestinal motility, ensuring smooth digestion and prevention of nausea caused by delayed gastric emptying.

2. Sustained-Release Technology: The SR formulation ensures a prolonged therapeutic effect, maintaining optimal drug levels in the body over an extended period for better symptom control and convenience.

3. Indications: Suitable for the management of GERD, erosive esophagitis, and chronic dyspepsia, Esohert-D addresses symptoms like bloating, regurgitation, nausea, and upper abdominal discomfort.

Hertz Pharma has designed Esohert-D with a focus on patient-centric care, ensuring both efficacy and safety. Its dual-action approach not only alleviates symptoms but also targets the root causes of acid reflux and motility disorders, promoting long-term esophageal healing. With adherence to stringent quality control standards, the product has gained trust among healthcare professionals and patients alike.

Esohert-D is generally prescribed once or twice daily, preferably before meals, to optimize its therapeutic benefits. While it is well-tolerated, patients should consult their healthcare provider before use, especially if they have underlying conditions such as liver or kidney impairment. Long-term use should be monitored to mitigate potential side effects such as nutrient malabsorption or rare extrapyramidal symptoms linked to Domperidone.

Esohert-D stands as a reliable and advanced solution for managing acid-related digestive disorders. Its combination of Esomeprazole and Domperidone not only ensures rapid symptom relief but also promotes sustained healing and improved digestive health. Backed by Hertz Pharma's commitment to quality and innovation, Esohert-D is an essential choice for those seeking effective and enduring relief from GERD and related conditions.